• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 124
  • 123
  • 15
  • 15
  • 10
  • 9
  • 6
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 345
  • 110
  • 94
  • 89
  • 78
  • 78
  • 75
  • 72
  • 47
  • 46
  • 42
  • 38
  • 38
  • 37
  • 33
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
211

Segmentos coronarianos sem obstrução angiográfica em indivíduos com doença aterosclerótica coronária: caracterização através do ultrassom intravascular com histologia virtual / Coronary segments without luminal stenosis by angiography in patients with atherosclerotic coronary disease: a comprehensive evaluation with intravascular ultrasound and virtual histology

Morais, Gustavo Rique 25 September 2015 (has links)
Introdução: Segmentos coronários com doença aterosclerótica manifesta podem coexistir no mesmo paciente com artérias normais à angiografia. Porém as características desses vasos angiograficamente normais permanecem pouco estudadas. O presente estudo visa a descrição in vivo, através do ultrassom intravascular com histologia virtual, da presença, grau de acometimento e composição da doença coronária aterosclerótica em artérias normais ou quase normais (irregularidades parietais) do ponto de vista angiográfico, em pacientes com doença coronária obstrutiva em outros territórios. Métodos: Pacientes com doença coronária obstrutiva foram selecionados de forma prospectiva e foram submetidos a estudo ultrassonográfico com histologia virtual de múltiplos vasos. Artérias epicárdicas principais foram classificadas em quatro grupos baseado na sua aparência angiográfica: 1) vasos completamente normais, 2) vasos com irregularidades parietais, 3) vasos com pelo menos uma estenose discreta, 4) vasos com pelo menos uma estenose moderada ou importante. Para os vasos com estenoses luminais (grupos 3 e 4 acima), apenas segmentos que não possuíam lesão maior ou igual a 30% (não obstrutivos) foram incluídos na análise. Resultados: Um total de 60 pacientes (154 vasos) foram incluídos no estudo. Vasos angiograficamente normais apresentaram menor carga de placa, menos componente necrótico, menor densidade de lesões e quase nenhuma placa com características de alto risco. Entretanto, em vasos com irregularidades parietais encontramos uma maior carga de placa com elevada densidade de lesões pelo ultrassom intravascular similar a segmentos \"não obstrutivos\" de vasos com estenoses luminais evidentes pela angiografia em outro ponto. Conclusão: Artérias coronárias completamente normais pela angiografia parecem apresentar pouca doença aterosclerótica. Entretanto, vasos com irregularidades parietais estão associados com um maior acometimento aterosclerótico e elevada densidade placas de alto risco, achado este que não pode ser rapidamente obtido com o uso apenas da angiografia coronária / Background: Extensively diseased arteries may co-exist, in the same patient, with coronary vessels with a normal appearance by angiography. Thus far, however, the characteristics of the latter remain poorly described. The present study aims to evaluate in vivo, using intravascular ultrasound (IVUS) with radiofrequency backscatter analysis (RF), the presence, degree, and composition of atherosclerosis in arteries with angiographically normal or near-normal appearance, in patients with diagnosed coronary disease in other territories. Methods: Patients with diagnosed obstructive coronary disease were prospectively selected and underwent protocol-mandated multi-vessel IVUS-RF. Major epicardial branches were classified into four groups based on their angiographic appearance: 1) completely normal-looking; 2) near-normal; 3) at least one mild stenosis; 4) at least one severe or moderate stenosis. For vessels with lumen stenosis (groups 3 and 4 above), only \"non-stenotic\" portions were included in the IVUS analysis. Results: A total of 60 patients (154 vessels) comprised the study population. Completely normal-looking vessels had lower plaque burden, lower necrotic component, lower density of lesions, and almost null high-risk plaques. Conversely, a nearnormal aspect, with only subtle lumen irregularities by angiography, was associated with increased disease burden, with an elevated density of plaques with high-risk features, similar to \"non-stenotic\" portions of vessels with obvious atherosclerosis elsewhere. Conclusions: Coronary vessels with a completely normal-looking appearance by angiography appear to have little atherosclerosis. Conversely, yet mild luminal irregularities by angiography are associated with increased disease burden and elevated density of high-risk plaques by IVUS, which cannot be readily assessable by angiography alone. Descriptors: angiography; atherosclerosis; coronary artery disease; plaque, atherosclerotic; ultrasonography, interventional; coronary vessels.Background: Extensively diseased arteries may co-exist, in the same patient, with coronary vessels with a normal appearance by angiography. Thus far, however, the characteristics of the latter remain poorly described. The present study aims to evaluate in vivo, using intravascular ultrasound (IVUS) with radiofrequency backscatter analysis (RF), the presence, degree, and composition of atherosclerosis in arteries with angiographically normal or near-normal appearance, in patients with diagnosed coronary disease in other territories. Methods: Patients with diagnosed obstructive coronary disease were prospectively selected and underwent protocol-mandated multi-vessel IVUS-RF. Major epicardial branches were classified into four groups based on their angiographic appearance: 1) completely normal-looking; 2) near-normal; 3) at least one mild stenosis; 4) at least one severe or moderate stenosis. For vessels with lumen stenosis (groups 3 and 4 above), only \"non-stenotic\" portions were included in the IVUS analysis. Results: A total of 60 patients (154 vessels) comprised the study population. Completely normal-looking vessels had lower plaque burden, lower necrotic component, lower density of lesions, and almost null high-risk plaques. Conversely, a nearnormal aspect, with only subtle lumen irregularities by angiography, was associated with increased disease burden, with an elevated density of plaques with high-risk features, similar to \"non-stenotic\" portions of vessels with obvious atherosclerosis elsewhere. Conclusions: Coronary vessels with a completely normal-looking appearance by angiography appear to have little atherosclerosis. Conversely, yet mild luminal irregularities by angiography are associated with increased disease burden and elevated density of high-risk plaques by IVUS, which cannot be readily assessable by angiography alone
212

Análise integrada de parâmetros clínicos, estruturais e funcionais nas fases aguda e não aguda da doença de Vogt-Koyanagi-Harada: estudo longitudinal / Integrated analysis of clinical, structural and functional parameters in the acute and non-acute phases of Vogt-Koyanagi-Harada disease: a prospective study

Sakata, Viviane Mayumi 06 July 2015 (has links)
OBJETIVO: Descrever prospectivamente o curso da doença de Vogt-Koyanagi-Harada (DVKH) com integração de parâmetros de atividades clínicos, estruturais e funcionais. MÉTODOS: Foram incluídos pacientes com diagnóstico da DVKH na fase aguda (parte I) e não aguda (tempo de doença maior que 12 meses; parte II). Os pacientes na fase aguda receberam tratamento inicial padronizado com pulsoterapia de metilprednisolona seguido de corticoterapia oral em doses lentamente regressivas, pelo período de 15 meses. As avaliações consistiram em exame clínico, retinografia, angiografias com fluoresceína (AGF) e indocianina verde (AIV) e tomografia de coerência óptica (TCO). Foram realizadas nos seguintes momentos: parte I, no diagnóstico e meses 1, 2, 4, 6, 9 e 12; parte II, na inclusão e a cada três meses. Eletrorretinograma campo total (ERGct) e eletrorretinograma multifocal (ERGmf) foram realizados na parte I, no 1.o mês e a cada seis meses e, na parte II, na inclusão e com 12 meses. A leitura dos exames, na parte I, foi efetuada por duas leitoras, não mascaradas; na parte II, foi realizada por três leitores mascarados e treinados, sendo considerada a leitura concordante entre, pelo menos, dois examinadores. As angiografias e TCO foram realizadas no aparelho Spectralis® (HRA+OCT, Heidelberg Engineering). Tratamento adicional com corticoterapia em doses imunossupressoras ou intensificação da imunossupressão sistêmica foi indicado nos casos com recidivas clínicas, na presença de sinais de atividade à AGF ou duas pioras consecutivas >= 30% no ERGct. Os sinais de atividade detectados na AGF, AIV e TCO foram denominados sinais subclínicos. RESULTADOS: Na parte I, foram incluídos nove pacientes (7F/2M) com idade mediana de 33 anos e intervalo mediano entre início dos sintomas e tratamento de 13 dias. Na apresentação inicial, sinais clínicos característicos da doença (coroidite difusa com hiperemia do disco óptico, descolamento seroso de retina e uveíte anterior acompanhados de sinais extraoculares) melhoraram dentro dos primeiros 30 dias em todos os casos. Os principais sinais subclínicos variaram no tempo de melhora ou desaparecimento: espessura de coroide (EC) subfoveal diminuiu para o valor mediano de 347u m aos 30 dias; dark dots diminuíram ao longo do seguimento, porém ainda estavam presentes aos 12 meses. Piora da inflamação foi observada em 17 de 18 olhos no tempo mediano de sete meses quando a redução do corticoide oral atingiu a dose média de 0,3mg/kg/d. Os sinais subclínicos mais frequentemente observados foram dark dots, fuzzy vessels e aumento da EC. Em 10 destes 17 olhos a piora foi acompanhada de queda da função pelo ERG. Três padrões de evolução puderam ser caracterizados: sem recidivas clínicas ou subclínicas (padrão A, 1 olho), com recidivas subclínicas somente (padrão B, 11 olhos) e com recidivas clínicas (padrão C, 6 olhos). Identificou-se que a EC aos 30 dias após início do tratamento >= 506u m teve sensibilidade e especificidade > 80% na detecção dos casos com recidivas clínicas (padrão C). A função pelo ERGct e ERGmf permaneceu alterada em relação ao grupo controle com 24 meses, apesar da melhora progressiva observada desde o início do tratamento. Na análise longitudinal dos pacientes, a função entre 12 e 24 meses permaneceu estável no grupo de doentes que recebeu tratamento adicional (8 olhos), enquanto no grupo que não o recebeu (4 olhos) houve deterioração da função ( < 0,001). Na análise dos grupos segundo padrão de recidiva, observou-se que os olhos com padrão B sem tratamento adicional tinham piora funcional maior em relação àqueles com padrão C ou B tratados (p < 0,001). Na parte II, foram incluídos 20 pacientes (17F/3M), com idade mediana ao diagnóstico de 31 anos, intervalo mediano entre início de sintomas e tratamento de 19 dias e tempo mediano de doença à inclusão de 55 meses. Na avaliação da concordância interobservador na leitura dos sinais subclínicos, EC teve concordância substancial (kappa=0,8), enquanto sinais angiográficos tiveram concordância sutil (kappa < 0,2). O curso da doença em 85% dos pacientes foi com recidiva clínica (padrão C, 11 casos) ou recidiva subclínica (padrão B, 6 casos). Nas 11 avaliações com detecção de células na câmara anterior (CA), sinais subclínicos de inflamação de segmento posterior foram concomitantemente observados em 64% dos olhos. Esta mesma concomitância de sinais subclínicos de inflamação de segmento posterior na presença de células na CA foi observada na parte I do estudo. Nos pacientes com padrão B, a variação da EC foi o principal sinal subclínico observado. A função pelo ERG foi realizada sequencialmente em 13 casos. Olhos com padrão C (7 pacientes), com grande comprometimento funcional desde a inclusão, evoluíram com piora mais acentuada do que aqueles com padrão B (5 pacientes). Ao se individualizar os olhos com padrão B, observou-se que esse diferencial (padrão B melhor que C) devia-se ao grupo padrão B com tratamento (p < 0,001). CONCLUSÕES: Neste estudo prospectivo de pacientes com DVKH em seguimento mínimo de 12 meses, desde as fases aguda e não aguda, três padrões de evolução foram observados, sendo que 94% (parte I) e 85% (parte II) dos pacientes apresentaram recidiva/piora clínica (padrão C) e/ou subclínica (padrão B). Na parte I do estudo, a piora da inflamação foi detectada aos sete meses de evolução durante dose regressiva do corticoide equivalente a 0,3mg/kg/d, apesar do tratamento inicial com corticoides em altas doses lentamente regressivo. A EC aferida 30 dias após o início do tratamento acima de 506 ?m mostrou-se um fator com sensibilidade e especificidade acima de 80% na identificação dos casos que evoluíram com recidivas clínicas. Dentre os sinais para detecção de inflamação subclínica, as alterações na EC são confiáveis, enquanto que sinais angiográficos devem ser interpretados com cautela. Exames sequenciais tornam a leitura mais confiável. A presença de células na CA comportou-se como a \"ponta do iceberg\" de uma inflamação mais difusa. O estudo eletrorretinográfico demonstrou resultado subnormal mesmo após 24 meses de seguimento na parte I; tratamento adicional pode evitar piora funcional nos pacientes com sinais subclínicos de inflamação. A pior função da retina em pacientes com inflamação clínica (padrão C) da parte II e dos pacientes com inflamação subclínica (padrão B) de ambas as partes do estudo sugerem que o tratamento ideal das recidivas inflamatórias ainda deve ser alvo de futuros estudos / OBJECTIVES: To describe the course of Vogt-Koyanagi-Harada disease (VKHD) prospectively, integrating clinical, structural and functional parameters. METHODS: Patients with VKHD in the acute (part I) and non-acute (more than 12 months from diagnosis) phases (part II) were included. Patients in the acute phase received a standard treatment with methylprednisolone pulsetherapy followed by high-dose oral corticosteroids with slow tapering during 15 months. Evaluations included clinical exams, fluorescein (FA) and indocyanine green (ICGA) angiographies and optical coherence tomography (OCT). In part I, they were performed at inclusion, then after 1,2,4,6,9,and 12 months; in part II, they were performed at inclusion then every 3 months for up to 12 months. Functional evaluation using electroretinography (ERG) was performed at inclusion and every 6 months in part I and at inclusion and at 12 months in part II. Two non-blinded readers analyzed the imaging exams in part I. In part II, three trained and blinded-readers performed the imaging exams analysis. For study`s purpose, at least two concordant readings were considered. Imaging exams utilized the Spectralis® (HRA+OCT, Heidelberg engineering). Inflammatory signs detected on FA, ICGA and OCT were denominated as subclinical signs. Additional treatment with high doses of corticosteroids or more intensive systemic immunosuppression was indicated in cases with clinical signs of inflammation, with subclinical signs on FA or with two consecutive worsening > 30% on ERG. RESULTS: Nine patients (7F/2M) were included in part I; median age was 33 years old and median time elapsed from onset of symptoms to treatment was 13 days. At disease presentation, classic signs (choroiditis, anterior uveitis, serous retinal detachment, optic disc hyperemia and extraocular manifestations) were observed; they improved in 30 days after treatment. Subclinical signs improved in variable periods of time: subfoveal choroidal thickness (CT) decreased to a median value of 347 ?m, 30 days after the beginning of treatment, dark dots diminished during the follow-up but they were still observed at 12 months. Relapse (worsening of inflammation) was noticed in 17 of 18 eyes at a median follow up time of seven months, when tapering schedule corticosteroid dosage reached the mean dose of 0.3mg/kg/d of prednisone. Dark dots, fuzzy vessels and choroid thickening were the most frequent subclinical signs. Relapses in 10 of 17 eyes were concomitant with worsening on ERG. Three patterns of evolution could be delineated: no signs of inflammation (pattern A, 1 eye), only subclinical signs of inflammation (pattern B, 11 eyes) and clinical signs of inflammation (pattern C, 6 eyes). CT>=506 ?m 30 days after the beginning of treatment was more than 80% sensitive and specific to detect more severe cases (pattern C). ERG parameters at 24 months were subnormal as compared to the control group, despite improvement during follow-up. Further long-term results after 24 month demonstrated stabilization of ERG parameters in patients that had received additional treatment, whereas there was worsening in those patients who had not received additional treatment (p<0.001). Moreover, pattern B patients without additional treatment had a further decrease on ERG values compared to results observed in pattern C or B patients with additional treatment (p<0.001). In Part II, 20 patients (17F/3M) were included; median age at diagnosis was 31 years old, median lag time from onset of symptoms and treatment was 19 days and median time after diagnosis was 55 months. The interobserver agreement for CT reading was substantial (kappa 0.8), whereas for angiographic signs was slight (kappa < 0.2). Recurrences, clinically (pattern C, 11 cases) or subclinically (pattern B, 6 cases) detected, were observed in 85% of cases. Concomitant inflammation of posterior segment detected by subclinical signs was present in 64% of cases with cells in anterior chamber. Simultaneous signs of subclinical inflammation of posterior segment and anterior uveitis were also observed in part I. CT change was the main subclinical sign observed in pattern B patients. ERG evaluation was performed in 13 cases. Pattern C cases (7 patients) presented worse results than pattern B cases (5 patients). Further analysis depicted that pattern B patients who had an additional treatment had better results than pattern B non-treated and pattern C (p<0.001). CONCLUSION: Three patterns of evolution were observed in VKHD patients during this prospective study, 94% (part I) and 85% (part II) presented recurrence/worsening with clinical (pattern C) or subclinical (Pattern B) signs of inflammation. In part I, worsening was observed at seven months after treatment start when reaching mean dose of 0.3mg/Kg/d of prednisone even after initial high-dose of corticosteroids followed by slow tapering. At day 30 after treatment, CT >= 506 ?m had a greater than 80% sensitivity and specificity to detect cases with pattern C evolution. Considering subclinical signs, CT increase reliably detected recurrence, whereas angiographic signs required cautious interpretation. Sequential analysis was more conclusive than an isolated exam. Anterior chamber cells seemed to be the \"tip of the iceberg\" of a more diffuse inflammation. ERG analysis was subnormal even after 24 months of follow up since disease onset; additional treatment could prevent functional worsening in patients with subclinical signs of inflammation. Worse retinal function in patients with clinical recurrences (pattern C) in part II and subclinical recurrences (pattern B) in parts I and II suggest that ideal treatment of recurrences should be further pursued
213

Comparação entre tomografia das artérias coronárias e ultrassonografia intracoronária na avaliação de pacientes submetidos a implante de suporte vascular bioabsorvível polimérico radiolucente / Comparison between computed tomography coronary angiography and intravascular ultrasound in measuring coronary segments of patients treated with a radiolucent bioresorbable vascular scaffold

Guimarães, Jorge Augusto Nunes 22 April 2014 (has links)
Introdução: A tomografia das artérias coronárias (ANGIO-TC) tem o potencial de medir as dimensões dos vasos e pode ser opção, aos métodos invasivos, para análises quantitativas em intervenções coronárias com suportes vasculares bioabsorvíveis (SVB) poliméricos radiolucentes. Objetivos: Medidas quantitativas pela ANGIO-TC do lúmen de segmentos coronários de pacientes submetidos a implante de um SVB com eluição de novolimus (DESolve®) foram comparadas às do ultrassom intracoronário (USIC). Os objetivos primários foram a comparação da área mínima e do volume do lúmen do SVB. Outros objetivos incluíram medidas nas margens do dispositivo, de referências do vaso e dos percentuais de estenose do SVB. A precisão de identificação do local de menor dimensão foi estimada pela distância entre este e a borda proximal do SVB. Método: Vinte e um pacientes submetidos a implante de um SVB DESolve e que foram reestudados após 6 meses com cinecoronariografia e USIC realizaram, também, ANGIO-TC. Sem conhecimento dos valores um do outro, um operador, em cada método, efetuou as medidas de volume, área e diâmetro mínimos do lúmen do SVB, de áreas e diâmetros mínimos do lúmen nas margens proximal e distal do SVB, de diâmetros e áreas de referência luminais e dos percentuais de estenose de diâmetros e áreas do SVB. Diferenças entre as médias foram significativas quando testes resultaram o valor de p< 0,05. Coeficientes de correlação foram calculados e a concordância foi analisada pelo método de Bland-Altman. Resultados: Os métodos não se mostraram correlacionados ao medirem área mínima do lúmen do SVB e a ANGIO-TC subestimou significativamente os valores em relação ao USIC (diferença de médias= -1,27 mm2; p= 0,004). As medidas do volume do lúmen do SVB mostraram correlação (r= 0,58; p= 0,006) e foram equivalentes (diferença de mediana= 5,4 mm3; p= 0,14). Em ambas, houve ampla variabilidade entre as medidas (variação percentual do erro de 128% para a área e de 119% para o volume). Os métodos mostraram correlações significativas para todas as demais variáveis. As médias das medidas de diâmetros, pela ANGIO-TC, não mostraram diferenças significativas em relação ao USIC. A ANGIO-TC subestimou significativamente as medidas da área mínima do lúmen no segmento distal ao SVB (diferença= -1,09 mm2; p = 0,017) e da área de referência dos vasos (diferença = -1,34 mm2; p = 0,008). Apesar do viés mínimo, os métodos mostraram ampla variação ao identificar o ponto de menor dimensão do SVB (erro percentual = 186%). A ANGIO-TC, assim como o USIC, não identificou casos de reestenose. Os métodos mostraram melhor nível de concordância ao medirem diâmetros e maiores discrepâncias ao estimarem percentuais de estenose. Conclusões: Em segmentos coronários com SVB polimérico, a ANGIOTC não obteve correlação e subestimou a área mínima do lúmen em relação ao USIC. Quantificações do volume do lúmen foram equivalentes e correlacionadas. Independentemente do nível de correlação, o padrão de concordância das medidas evidenciou um nível de acurácia insatisfatório para a ANGIO-TC substituir o USIC para quantificações de lumens em estudos com SVB radiolucentes, embora permaneça útil para análises visuais na prática clínica. / Computed tomography coronary angiography (CTA) is able to quantify vessel dimensions and might potentially be an alternative to substitute invasive methods for quantitative analysis in percutaneous coronary interventions with bioresorbable vascular scaffolds (BVS). This study compared quantitative measurements derived from CTA images to intravascular ultrasound (IVUS) in coronary segments implanted with radiolucent DESolve(TM) novolimuseluting BVS. Primary objectives were comparisons of BVS minimal luminal area and luminal volume in BVS. Secondary objectives included comparisons of minimal luminal areas and diameters in proximal and distal segments to the BVS, luminal vessel reference areas and diameters and BVS percent area and diameter stenosis. Precision of identifying BVS luminal minimal area were assessed by measuring distance from this point to proximal BVS border. Twenty-one patients underwent both CTA and IVUS, six months after BVS deployment. Each method was performed by an experienced operator, blinded to other\'s quantifications. Correlation coefficients were calculated and mean differences with 95% limits of agreement were assessed by Bland-Altman analysis. A p-value less than 0.05 were considered statistically significant. CTA did not show correlation to IVUS and significantly underestimated minimal luminal area in BVS (mean differences = -1.27 mm2; p = 0.004). Quantitative measurements of luminal volume in BVS were equivalent (median difference = 5.4 mm3; p = 0.14) and showed modest correlation (r= 0.58; p= 0.006). Both variables showed wide limits of agreement (percent error = 128% in minimal luminal area and 119% in luminal volume). Correlations were significant in all other variables. Both methods did not show significant differences quantifying all-segment diameters, and percent area and diameter stenosis. CTA significantly underestimated measurements of minimal luminal area in distal segment after BVS (mean difference = -1,09 mm2; p = 0,017) and luminal reference area (mean difference = -1,34 mm2; p = 0,008). CTA and IVUS showed nonsignificant bias to identify BVS luminal minimal area, but very wide limits of agreement (percent error= 186%). Both methods agreed in showing no cases of binary restenosis. Regardless of correlations or mean differences, all measures showed high variability, caracterized by wide limits of agreement. The least variations resulted from diameter quantifications, whereas estimated percent stenosis presented more disparities. These discrepancies between both methods showed that CTA analysis is still not fully developed to replace IVUS in the assessment of quantitative measurements in vessels treated with BVS. It remains, however, clinically useful for visual qualitative analysis.
214

Avaliação tardia dos stents liberadores de Biolimus A9® pela tomografia de coerência óptica: análise da cobertura tecidual e da aposição das hastes / Long-term follow-up Biolimus A9TM stents with optical coherence tomography: strut apposition and tissue coverage analysis

Staico, Rodolfo 04 July 2011 (has links)
Introdução: Os stents farmacológicos (SF) de primeira geração surgiram com o intuito de reduzir as taxas de reestenose intra-stent e de revascularização da lesão-alvo, sendo mais eficazes quando comparados aos stents não-farmacológicos (SNF), porém com aumento de risco de trombose do stent (TS) muito tardia. A cobertura tecidual incompleta e a má aposição tardia das hastes dos stents podem estar vinculadas à TS. O SF de segunda geração BioMatrix®, que utiliza um polímero bioabsorvível, surgiu na expectativa de redução da TS. Devido à alta acurácia e reprodutibilidade e à análise precisa da cobertura tecidual e da aposição das hastes dos stents, a tomografia de coerência óptica (TCO) vem se tornando um método útil na análise desses aspectos. O objetivo desse estudo foi avaliar a cobertura tecidual e a aposição das hastes do SF BioMatrix® após longo período do implante. Métodos: Vinte pacientes submetidos ao implante do SF BioMatrix® (n = 15) ou do SNF S-Stent® (n = 5) foram acompanhados por um período mínimo de cinco anos e avaliados por meio da angiografia coronária quantitativa (ACQ), da ultrassonografia intracoronária (USIC) e da TCO. Para a análise estatística, foram utilizados os programas SPSS® versão 16.0 e SAS versão 9.2. O valor de p < 0,05 era considerado estatisticamente significante. As variáveis categóricas foram expressas em números absolutos e porcentuais e comparadas pelo teste exato de Fisher. As variáveis contínuas foram expressas em média e desvio padrão e/ou mediana e intervalo interquartílico e foram comparadas pelo teste não paramétrico de Mann-Whitney. Resultados: A ACQ demonstrou diferença, porém não significativa na perda tardia da luz entre o SF BioMatrix® e o S-Stent® [0,40 (0,21; 0,77) mm vs 0,68 (0,66; 0,82) mm, p = 0,205]. Os pacientes tratados com o SF BioMatrix® apresentaram porcentual de obstrução do stent significativamente menor quando comparados àqueles que receberam o S-Stent® [5,6 (4,4; 9,7)% vs 28,6 (24,7; 29,0)%, p =0,001]. A análise da TCO demonstrou 126 (8,7%) hastes não cobertas nos stents BioMatrix® e 23 (4,0%) nos S-Stents® (p = 0,297), estando a maioria delas bem apostas (117/126 e 21/23, respectivamente, p = 0,292). Apenas nove (0,6%) hastes nos SF e duas (0,4%) hastes nos SNF estavam simultaneamente sem cobertura tecidual e mal apostas (p = 0,924). No grupo BioMatrix®, apenas 1 (11,1%) paciente teve todas as hastes cobertas. Já no grupo S-Stent, 66,7% dos pacientes (2/3) apresentaram cobertura completa das hastes (p = 0,127). Conclusões: A avaliação tardia do SF BioMatrix® pela TCO mostrou cobertura tecidual e aposição em quase a totalidade de suas hastes, de maneira similar àquela encontrada nos SNF S-Stents®. / Introduction: First generation drug-eluting stents (DES) have emerged as a strategy to prevent in-stent restenosis and the need of target-vessel revascularization when compared to bare metal stents (BMS); but at the expense of a higher risk of very late stent thrombosis (ST). Uncovered and malapposed struts may be associated with both late and very late ST. It has been postulated that the second generation DES, the biolimus-eluting stent BioMatrixTM with biodegradable polymer, may reduce the incidence of ST. Given its high accuracy and reproducibility with precise analysis of the complete strut apposition and strut coverage, the optic coherence tomography (OCT) has been extensively used for stent analysis. The aim of this study was to assess the struts coverage and apposition of DES BioMatrixTM in a long-term follow up. Methods: Twenty patients undergoing a BioMatrixTM (n = 15) or BMS S-StentTM (n = 5) implantation were followed up for a period of at least five years and evaluated by means of OCT, quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS). All statistical analyses were performed using SPSSTM (v.16.0) and SAS (v.9.2) software. Statistical significance was considered at p values < 0.05. Categorical variables were expressed as counts and percentages, and continuous variables as mean SD and/or median and interquartile range. For per-patient level comparison, the difference between two stent types was evaluated by nonparametric Mann-Whitney U test while categorical variables were evaluated by the Fisher exact test. Results: QCA analysis showed no differences in the occurrence of intrastent late loss between the groups [0.40 (0.21; 0.77) mm vs 0.68 (0.66; 0.82) mm, p = 0.205 for BioMatrixTM and S-StentsTM, respectively]. The vessel, stent and lumen volumes assessed by IVUS after the procedure and 5 years later were similar between the two groups. Patients treated with BioMatrixTM had significantly less stent obstruction percentage when compared to those treated with S-StentTM [5.6 (4.4; 9.7)% vs 28.6 (24.7; 29.0)%, p = 0.001]. OCT analysis demonstrated 126 (8.7%) uncovered struts in the BioMatrixTM group compared to 23 (4.0%) in the S-StentsTM group (p = 0.297), being the majority of them well apposed (117/126 and 21/23, respectively, p = 0.292). Only 9 (0.6%) struts in the DES and 2 (0.4%) struts in the BMS groups were imultaneously uncovered and malapposed (p = 0.924). Among the BioMatrixTM patients, 55.6% (5/9) had more than 95% of covered struts and in only 1 (11.1%) patient all struts were covered. On the other hand, among the S-StentTM patients, 66.7% (2/3) had complete covered struts (p = 0.127). Conclusion: Long term assessment of DES BioMatrixTM by OCT showed tissue coverage and apposition in almost all struts, similary to those found in the BMS S-StentsTM.
215

Tratamento endovascular das fístulas carotidocavenosas indiretas / Endovascular treatment of indirect carotid-cavernous fistulas

Silva, André Goyanna Pinheiro 27 November 2006 (has links)
As fístulas arteriovenosas da região do seio cavernoso constituem as fístulas carotidocavernosas que podem ser diretas ou indiretas. As indiretas são raras, a sua sintomatologia é variada e o tratamento é controverso. Este estudo compreendeu a análise prospectiva de 44 pacientes portadores de fístulas carotidocavernosas indiretas (FCCI) no período de 01 de janeiro de 1994 e 31 de janeiro de 2004, 42 com etiologia espontânea e dois pacientes com etiologia traumática, sendo estes analisados separadamente. Doze (12) pacientes foram submetidos à conduta expectante e orientados a realizar manobras de compressão carótido-jugular. O tratamento endovascular foi realizado por via arterial, venosa ou combinação dos dois, num total de 30 pacientes. Considerando o grupo inteiro, ocorreu trombose espontânea em aproximadamente 24% dos pacientes. Os sintomas e o aspecto angiográfico após o tratamento evoluíram com melhora ou cura em 100% dos casos, com oclusão completa das FCCI em 63,3%, a grande maioria destes submetidos a apenas um procedimento. Além dos acessos venosos tradicionais aos seios cavernosos, vias de acesso alternativas através da veia oftálmica superior foram realizadas por punção percutânea de veia facial, veia supratroclear ou veia frontal. O material embolizante mais utilizado foi o adesivo tissular líquido, \"cola\", isoladamente ou em conjunto com outros materiais. Houve complicações transitórias em 13,3% dos pacientes tratados e nenhuma complicação permanente foi observada, o que demonstrou a baixa morbidade deste procedimento / The arteriovenous fistulas of the cavernous sinus (CS) region constitute the carotid-cavernous fistula, which can be direct or indirect. The indirect type is quite rare, its clinical features is very inespecific and its treatment modalities controversial. Forty-four patients with indirect carotid-cavernous fistulas (ICCF) were studied in a prospective manner between January 1994 to January 2004, 42 with spontaneous etiology and 2 with traumatic etiology, being these analyzed separately. Twelve (12) patients were submitted to a expectant management and instructed to perform carotid-jugular compression. Endovascular treatment was accomplished by arterial approach, vein approach or combination of both, in a total of 30 patients. Considering the entire group, spontaneous thrombosis was observed in approximately 24%. Symptoms and the angiographic features after endovascular treatment improved or disappeared in 100% of the cases, with total obliteration in 63.3%, most of them submitted to just one procedure. Despite the traditional venous routes to the CS, alternative accesses through the superior ophthalmic vein (SOV) were accomplished by percutaneous puncture of the facial, supratrochlear or frontal vein. Liquid adhesive (glue) was the most often embolic material used isolated or with other materials. No permanent complication was observed and only 13,3% of the patients treated cursed with transitory complications, what demonstrated the low morbidity of this procedure
216

Remodelamento tardio da artéria torácica interna bilateral na revascularização do miocárdio: Influência do leito coronariano esquerdo / Late remodeling of bilateral internal thoracic artery in coronary artery bypass graft surgery: influence of left coronary bed

Rocha, Bruno da Costa 20 February 2006 (has links)
O enxerto de artéria torácica interna tem demonstrado capacidade de remodelamento devido a interação com o leito arterial coronariano. O objetivo deste estudo foi analisar a influência dos fatores clínicos e angiográficos no remodelamento dos enxertos, definido como variação no calibre vascular. Casuística e métodos: No período entre 1983 e 1999, 356 pacientes realizaram cirurgia de revascularização do miocárdio utilizando a artéria torácica interna esquerda para o ramo interventricular anterior e a artéria torácica interna direita para um ramo da circunflexa. Trinta e dois pacientes foram submetidos a cineangiocoronariografia pós-operatória, a qual foi posteriormente analisada com o aplicativo CASS II®. Este estudo observacional apresentou acompanhamento médio de 42 meses(6-204 meses). As variáveis angiográficas analisadas foram os diâmetros proximal e distal dos enxertos arteriais (variável dependente), área coronariana, pontuação de fluxo TIMI, diâmetro de estenose proximal, fluxo dominante distal e ramos patentes. Fatores de risco cardiovascular também foram incluídos. Resultados: O modelo de regressão linear múltiplo demonstrou um R2ajustado=0,69 (p=0,0001) para o modelo a direita e R2ajustado=0,46 (p=0,002) para a esquerda. Os enxertos apresentaram diâmetros proximal e distal de 2,67mm ±0,085 e 2,232mm ±0,085 à esquerda; 2,458mm ±0,088 e 2,010mm ± 0,091 (média±EP) à direita, respectivamente (p>0,05). Nenhuma variável clínica obteve correlação significante estatisticamente. A área coronariana apresentou coeficiente de beta=0,42 (0,14-0,6/IC-95%) e diâmetro de estenose proximal de 0,55 (0,40-0,65/IC-95%) para o remodelamento do lado direito. A área coronariana demonstrou coeficiente de beta=0,54 (0,3- 0,68/IC-95%) para o remodelamento do lado esquerdo. Conclusões: A artéria torácica interna não demonstrou diferença de calibre em relação a lateralidade (esquerda vs direita). O diâmetro de estenose proximal da artéria coronária revascularizada demonstrou correlação positiva com o remodelamento dos enxertos do lado direito. A área da artéria coronária revascularizada foi a única variável de influência para o remodelamento bilateral dos enxertos / Internal thoracic artery grafts has demonstrated capacity for remodeling due to interaction with the coronary artery bed. The goal was to analysis the influence of clinical and angiographic factors in this remodeling as defined as grafts caliber variation. Methods: In a period from 1983 to 1999, 356 patients underwent to coronary artery bypass surgery using the left internal thoracic artery anastomosed to interventricular anterior branch and the right internal thoracic artery to circumflex branches. Thirty two patients were submitted to postoperative coronary angiography which was further analysed by CASS II® software. The mean follow-up of this observational study was 42 months(6- 204 months). Angiographic variables analyzed was proximal and distal diameters of arterial grafts(dependent variable), coronary area, TIMI flow grade, proximal stenosis diameter, dominant distal flow and patent branches. Cardiovascular risk factors were included indeed. Results: The multiple regression model demonstrated R2adjusted=0.69 (p=0.0001) for right side and R2adjusted=0.46 (p=0.002) for left side. The grafts presented proximal and distal diameters of 2.67mm ±0.085 and 2.232mm ±0.085 from left side; 2.458mm ±0.088 and 2.010mm ±0.091 (mean±SE) from right side respectively (p > 0,05). None of the clinical variables had statistical significant correlation. The coronary area presented as a beta coefficient=0.42 (0.14-0.6/CI-95%) and proximal stenosis diameter of 0.55 (0.40-0.65/CI-95%) for right side remodeling. The coronary area shown a beta coefficient=0.54 (0.3- 0.68/CI-95%) for left side remodeling. Conclusions: The internal thoracic artery did not demonstrate difference in caliber about its laterality (left vs right). The proximal stenosis degree of the bypassed coronary artery demonstrated positive correlation with remodeling for the right side grafts. Bilateral grafts remodeling was only explained by positive correlation with the bypassed coronary area
217

Doença oclusiva da artéria basilar: aspectos clínicos e radiológicos / Basilar artery occlusive disease: clinical and radiological aspects

Ciríaco, Jovana Gobbi Marchesi 21 October 2008 (has links)
O objetivo deste estudo foi descrever as características demográficas, clínicas, radiológicas e o prognóstico da doença oclusiva da artéria basilar (DOAB), em uma população multiétnica. Foram estudados 40 indivíduos com infartos no território da artéria basilar (AB) confirmados por ressonância magnética, que sobreviveram após 30 dias à fase aguda do acidente vascular cerebral isquêmico (AVCI). Todos os doentes apresentavam estenose ³ 50% ou oclusão da AB, documentada por angiografia por ressonância ou angiografia digital. Foram registrados: idade, sexo, grupo étnico, fatores de risco para doença vascular, quadro clínico na instalação do AVCI, local do infarto, segmento arterial acometido, grau de estenose e presença de circulação colateral. A escala modificada de Rankin (EMR) em 30 dias e após seis meses do evento isquêmico foi avaliada, assim como a taxa de recorrência de eventos vasculares isquêmicos. Associações entre dados demográficos, aspectos clínicos, radiológicos e prognóstico foram analisadas pelo teste da razão de verossimilhança ou pelo teste exato de Fisher. A comparação entre a pontuação na EMR em 30 dias e seis meses foi realizada pelo teste de Wilcoxon. Sessenta por cento dos pacientes eram homens e 33%, afro-brasileiros. A média (± desvio-padrão) de idade foi 55,8 ± 12,9 anos. A maioria (90%) dos pacientes apresentou múltiplos fatores de risco para doença vascular. Ataques isquêmicos transitórios (AIT) precederam os AVCIs em 48% dos casos. Antecedente de hipertensão arterial sistêmica (HAS) esteve presente em 80% dos doentes. O sintoma mais comum foi vertigem/desequilíbrio. A maioria dos infartos localizou-se na ponte (85%) e o terço médio da AB foi o mais freqüentemente afetado (33%). Oclusão arterial esteve presente em 58% dos casos. Lesões mais graves foram observadas em caso de acometimento do terço médio da AB (p=0,001). Aterosclerose de grandes artérias foi a etiologia mais comum do AVCI (88%), sendo mais freqüente nos pacientes acima de 45 anos (p<0,001). Somente um paciente foi tratado com trombólise intra-arterial e a maioria foi tratada com anticoagulação na fase aguda. A pontuação na EMR melhorou significativamente após seis meses (p<0,001). Podemos concluir que obtivemos alguns resultados diferentes de outras séries de países desenvolvidos, como maior proporção de afrodescendentes e oclusão da AB em pouco mais da metade dos casos. Taxas de AIT precedendo o AVCI, freqüência alta de aterosclerose como etiologia e bom prognóstico funcional foram semelhantes a descrições da literatura. Estes resultados representam um avanço no conhecimento da DOAB em nosso meio / The aim of this study was to describe demographical, clinical, radiological findings and outcome in stroke survivors with basilar artery occlusive disease (BAOC). We studied 40 patients with infarcts in the basilar artery (BA) territory confirmed by magnetic resonance imaging (MRI), who survived for at least 30 days after acute stroke. All patients had ³ 50% BA stenosis or occlusion, documented by magnetic resonance or digital subtraction angiography. The following characteristics were registered: age, sex, ethnical group, vascular risk factors, symptoms and signs, infarct location, site and degree of BA stenosis, and presence of collateral circulation. Modified Rankin Scale (MRS) scores at 30 days and six months after the ischemic event were evaluated, as well as transient ischemic attack (TIA) and stroke recurrence rates. Associations between demographical, clinical, radiological features and outcome were analyzed with Likelihoodratio and Fisher´s exact tests. The comparison between MRS scores at 30 days and six months was made with the Wilcoxon test. Sixty percent of the patients were male and 33% were Afro-Brazilian. Mean age was 55.8 ± 12.9 years. Most of the subjects (90%) had multiple vascular risk factors. TIAs preceded strokes in 48% of the patients. Eighty per cent had history of arterial hypertension. The most common neurological symptom was vertigo/dizziness. Most of the infarcts were located in the pons (85%) and the BA middle third was the most frequently affected segment (33%). BA occlusion occurred in 58% of the patients. More severe lesions were present in patients with occlusive disease in the middle third of the BA (p=0.001). Large-artery atherosclerosis was the most common stroke etiology (88%) and was more frequent in patients older than 45 years (p<0.001). Only one patient was treated with intra-arterial thrombolysis and most of the others received anticoagulation. MRS scores improved significantly at six months (p<0.001). In conclusion, we observed different results compared with other series, such as: greater proportion of afrodescendents, higher frequency of atherosclerosis and BA occlusion. Rates of preceding TIAs and good outcome at six months were similar to previously published data. These results represent a step forward towards understanding BAOC in a large Brazilian urban center
218

Schlaganfall-Bildgebung mittels Mehrschicht-Spiral-CT

Bohner, Georg 21 February 2005 (has links)
Es wurde der Einsatz der Mehrschicht-Spiral-CT (MS-CT) zur zerebralen Perfusionsbildgebung und zur zerviko-zerebralen Angiographie bei Schlaganfallpatienten evaluiert. Bei 52 Patienten mit klinischen Zeichen einer akuten Ischämie wurde im Mittel 3,4 Stunden nach Symptombeginn an einem MS-CT Gerät eine CT-Perfusion (CTP) durchgeführt. Parameterbilder der zerebralen Blutperfusion (CBP), des zerebralen Blutvolumens (CBV) und der mittleren Transitzeit (MTT) wurden generiert, Perfusionsstörungen ermittelt und mit bildgebenden sowie klinischen Verlaufskontrollen korreliert. Eine CT-Angiographie (CTA) wurde initial bei 12 Patienten angewandt, um die Eignung des Untersuchungsprotokolls zu prüfen. Darüber hinaus wurden bei 45 Patienten mit Zeichen einer akuten zerebrovaskulären Insuffizienz die Ergebnisse der CTA mit denen anderer bildgebender Modalitäten (Magnetresonanz-Angiographie, digitale Subtraktionsangiographie, Dopplerultraschall) verglichen. Perfusionsbilder konnten von 44 Patienten generiert werden, hiervon entwickelten 22 Patienten einen im Verlauf gesicherten Infarkt. An Hand der MTT-Bilder konnten ischämische Veränderungen mit einer Sensitivität von 95 % erfasst werden, die Spezifität war mit 100 % für die CBV-Bilder am höchsten. Patienten mit Infarkt zeigten seitenvergleichend eine signifikante Reduktion der CBP in ischämischen Arealen. Die Ausdehnung der CBV Reduktion ergab die beste Korrelation mit dem endgültigen partiellen Infarktvolumen. Mit der CTA konnte anfänglich bei 12 / 12 Patienten, später bei 43 / 45 (96 %) eine umfassende Darstellung des zerviko-zerebralen Gefäßsystems erreicht werden, wobei in 22 Infarktpatienten die zu Grunde liegende Gefäßpathologie erkannt werden konnte. Das evaluierte Protokoll zur Perfusionsbildgebung mittels Mehrschicht-Spiral-CT ist zur frühzeitigen Erkennung und Quantifizierung einer akuten zerebralen Ischämie geeignet und bietet zusammen mit der CTA, welche das gesamte zerviko-zerebrale Gefäßsystem verlässlich visualisieren kann, die Möglichkeit einer umfassenden Bildgebung mittels MS-CT bei Schlaganfallpatienten. / The application of multi-slice spiral computed tomography (MS-CT) in the diagnostic assessment of stroke patients using cerebral perfusion imaging and cervicocerebral angiography was evaluated. Fifty-two patients with clinically suspected acute ischemia underwent CT perfusion (CTP), performed 3.4 hours, on average, after the onset of symptoms, by using MS-CT. Perfusion images of the cerebral blood perfusion (CBP), cerebral blood volume (CBV) and mean transit time (MTT) were calculated. The amount and extension of perfusion disturbances were measured and correlated with the outcome. CT angiography (CTA) was initially performed on twelve patients to verify the suitability of the examination protocol. In addition, forty-five patients with signs of acute cerebrovascular insufficiency underwent CTA. CTA findings were compared with those of other imaging modalities (magnetic resonance imaging, digital subtraction angiography, doppler ultrasonography). Of 44 patients in whom perfusion maps could be generated, 22 developed infarction confirmed at follow-up. On MTT-maps ischemic changes could be detected with the highest sensitivity (95%). Specificity was highest (100%) for CBV-maps. Patients with infarction showed significant reduction of CBP in ischemic tissue compared to the contra lateral hemisphere. Extension of CBV reduction showed the best correlation with final infarct volume. Initially in twelve out of twelve patients, later in 43 out of 45 (96%), the cervicocranial vascular system could be comprehensively visualized using CTA. In 22 stroke patients the underlying vascular pathology could be detected. CT perfusion using multi-slice CT is a suitable tool for the early identification and quantification of acute cerebral ischemia. Multi-slice CT angiography permits reliable visualization of the cervicocranial vascular system. Together these tools offer comprehensive assessment of stroke patients by means of multi-slice CT.
219

Ergebnisse der CT-Angiographie bei der Diagnostik von Nierenarterienstenosen

Ludewig, Stefan 06 November 2000 (has links)
EINLEITUNG: Die CT- Angiographie (CTA) ist eine neue Methode zum anatomischen Nachweis pathologischer Veränderungen am Gefäßsystem. Die Wertigkeit der an unserem Institut durchgeführten CT- Angiographien bezüglich der Diagnostik von Nierenarterienstenosen sollte untersucht werden. Außerdem sollten die einzelne Rekonstruktionsarten auf ihren Nutzen geprüft werden. MATERIAL UND METHODEN: Die Nierenarterien von 23 Patienten wurden sowohl angiograpisch als auch mit CTA untersucht. Aus dem Datensatz jeder Untersuchung wurden Axiale Schnittbilder (AS), axiale und coronale multiplanare Reformationen (cMPRa, cMPRc), 3D- Oberflächenrekonstruktion (SSD) und Maximum- Intensitäts- Projektion (MIP) angefertigt. Ohne Kenntnis des Angiographie- Befundes wurden in der ersten Befundungssitzung alle CTA- Rekonstruktionen einzeln beurteilt. Dabei kam eine fünfteilige Stenosengraduierung zum Einsatz. In der zweiten Befundungssitzung wurde die Diagnose anhand aller CTA- Rekonstruktionen eines Falles gestellt. Sensitivität, Spezifität und Kappa ergaben sich aus dem Vergleich mit den Angiographie- Befunden. ERGEBNISSE: Die CTA konnte relevante Nierenarterienstenosen (Lumeneinengung >50%) mit einer Sensitivität von 92,9 % und einer Spezifität von 86,7 % nachweisen. Der CTA- Stenosegrad stimmte bei Anwendung einer Unterteilung in fünf Kategorien in 65,9 % der Fälle mit dem der Angiographie überein (kappa = 0,468). Bei der Beurteilung der einzelnen Rekonstruktion lieferten die AS (Sensitivität 78,6 %, Spezifität 90,0 %, kappa 0,692) und die MIP (Sensitivität 71,4 %, Spezifität 96,7 %, kappa 0,726) die besten Resultate. Die cMPRa und cMPRc besaßen durch die ausschließliche Filmbefundung eine deutlich niedrigere diagnostische Qualität. Tendenziell wurde der Stenosegad mittels CTA unterschätzt. SCHLUSSFOLGERUNG: Die CTA besitzt eine hohe Wertigkeit bei der Diagnostik von Nierenarterienstenosen. Unsere Ergebnisse decken sich mit denen anderer Studien. Der Einsatz der CTA bei Verdacht auf eine Nierenarterienstenose kann die Zahl unnötiger Angiographien deutlich reduzieren. Zur Befunderhebung sollten die AS und die MIP regelmäßig genutzt werden. / PURPOSE: To evaluate the accuracy of Computed Tomographic Angiography (CTA) in the detection of renal artery stenosis in our department and to investigate the role of the different reformattings in making the right diagnosis. MATERIALS AND METHODS: CTA and conventional Arteriography were performed on 23 Patients and axial slices (AS), curved axial multiplanar reformatting (cMPRa), curved coronal multiplanar reformatting (cMPRc), shaded surface display (SSD) and maximum intensity projections (MIP) were performed. During the first reading- session all blinded images were reviewed seperately, while all reformattings of one patient were analysed in the second reading session by one experienced radiologist, using a five- point- scale to determine the grade of the stenosis. RESULTS: Stenoses greater than 50% could be depicted by CTA with a sensitivity of 92,9 % and a specifity of 86,7 %. Applying a 5 five- point- scale, 65,9% of the diagnoses met the ones made by angiography (kappa= 0,468). MIP and AS were the most usefull reformattings with sensitivity, specifity and kappa reaching 71,4 %, 96,7 %, 0,726 and 78,6 %, 90 %, 0,692respectively. A tendency for underestimating the degree of the stenoses was notable. CONCLUSIONS: CTA has a high accuracy in diagnosing renal artery stenoses. Our results do not differ much from other studies on this technique. Applying CTA in suspected renal artery stenosis can reduce the amount of unnessecary arteriographies. For best results, MIP and AS should always be reviewed.
220

Durale Sinus cavernosus Fisteln

Benndorf, Götz 15 July 2002 (has links)
Die durale Fistel des Sinus cavernosus (DSCF) ist eine seltene Erkrankung, die durch kleine abnorme arteriovenöse Verbindungen zwischen A. carotis interna bzw. externa und dem Sinus cavernosus gekennzeichnet ist. Bei nicht entsprechender Diagnostik kann es zu Verschleppung der Diagnose und erheblicher Beeinträchtigung der Patienten bis zum vollständigen Visusverlust kommen. Aus diesem Grund ist die rechzeitige Erkennung der Erkrankung wichtig und für eine effektive therapeutische Maßnahme von Bedeutung. MRT und CT können Anhaltspunkte für eine Verdachtsdiagnose liefern und spielen eine wesentliche Rolle bei der Suche nach intrakraniellen Blutungen oder Infarzierungen. Zum sicheren Ausschluß von insbesondere kleineren Fisteln und mehr noch zur genaueren Therapieplanung ist jedoch die intraarterielle DSA nach wie vor unerlässlich, vor allem um Verwechslungen mit anderen Erkrankungen, wie z. B. endokrine Orbitopathie oder Myositis, zu vermeiden. Die Behandlung der DSCF besteht heute vor allem in der Anwendung endovaskulärer Techniken. In der vorliegenden Studie wurden 26 von insgesamt 29 Patienten durch diese Technik behandelt und bei allen ein vollständiger Verschluß erzielt (100%; angiographische Verlaufskontrolle bei 22 Patienten). Die Rate der klinischen Heilung insgesamt betrug 96%, bei einer Komplikationsrate von 3% für ein transientes neurologisches Defizit (Abduzensparese bei einer Patientin). Die endovaskuläre Behandlung von DSCF durch transvenöse Embolisation durch einen erfahrenen Spezialisten stellt heute aufgrund ihrer hohen Effektivität und niedrigen Komplikationsrate die Methode der Wahl dar. Hierbei sind gesteuert ablösbare Platincoils das zu bevorzugende Embolisat. Der Einsatz aggressiver Behandlungsmethoden, insbesondere mikrochirurgischer Techniken bei sogenannten "nicht embolisierbaren Fisteln", hat damit seine Berechtigung weitgehend verloren. / The dural fistula of the cavernous sinus (DCSF) is a rare disease, characterized by abnormal arteriovenous communication between the internal or external carotid artery and the cavernous sinus. Inadequate diagnostic procedures may delay the correct diagnosis as well as the appropriate therapeutic management with deterioration of the patient's symptoms and possible visual loss. Therefore, early recognition of the disease is important for effective therapeutic management. MRI and CT may be helpful in leading to the diagnosis and play an important role in excluding intracranial hemorrhage or infarction. For definite diagnosis, in particular of small low-flow fistulas and to avoid misdiagnosis such as endocrine orbitopathy or myositis as well as for therapeutic planning, intraarterial DSA is still mandatory. Therapeutic management of DCSFs today consists mainly in performing endovascular techniques. In the here presented study, 26 of 29 patients were treated using transvenous embolization. Complete occlusion was achieved in 100% (angiographic follow-up available in 22 patients). Clinical cure was achieved in 96%. The complication rate was 3% for transient neurological deficit (6th nerve palsy in one patient). Because of its high success rate and the low complication rate, endovascular treatment of DCSF using transvenous embolization by an experienced operator represents today the method of choice. Detachable platinum coils is the preferable embolic agent. More aggressive methods, in particular microsurgical techniques in cases of so-called "intractable fistulas" should no longer be used.

Page generated in 0.106 seconds